Blood Test Predicts Alzheimer’s Risk
The introduction of a new blood test offers insights into predicting Alzheimer’s disease risk. Dr. Jeremy Koppel outlines how this test detects abnormal protein accumulation, which is crucial in diagnosing symptomatic individuals.
A Finnish study suggests that certain medical conditions might indicate early-onset Alzheimer’s years before patients receive a diagnosis. Researchers identified conditions like depression, vertigo, and headaches as more common during the five years leading up to diagnosis, potentially serving as early detection signals.
Study Insights
The study analyzed medical records of 407 people with early-onset Alzheimer’s and 4,035 individuals without the diagnosis, focusing on a 15-year period before the condition was identified. The average diagnosis age was 60, noting early-onset in those younger than 65.
Certain medical conditions may signal early-onset Alzheimer’s disease several years before diagnosis.
Key Findings
- Vertigo: 5.9% diagnosed vs. 2.1% not diagnosed
- Depression: 5.7% vs. 2.3%
- Headache: 4.9% vs. 1.6%
- Stroke: 4.4% vs. 2.0%
- Alcohol-related disorders: 3.4% vs. 1.4%
- Brain disorders: 2.9% vs. 0.9%
- Thyroid disorders: 2.5% vs. 0.8%
- Epilepsy: 2.2% vs. 0.7%
- Delirium: 1.5% vs. 0.1%
- Ear, nose, and throat disorders: 5.2% vs. 2.9%
The differences in these medical conditions became most pronounced during the five years just before an Alzheimer’s diagnosis was made.
The Importance of Early Detection
Suvi-Johanna Krüger, M.D., Ph.D., notes, “Neuropathological changes linked to Alzheimer’s start at least 15 to 20 years before symptoms.” This study highlights a focus on early-onset Alzheimer’s, a less explored area compared to late-onset Alzheimer’s.
Study Limitations and Future Research
This observational study highlights associations but does not confirm that these conditions predict Alzheimer’s. The researchers acknowledge they cannot determine if these conditions cause or result from the disease. Factors such as genetics, lifestyle, and socioeconomic elements may influence outcomes. Krüger emphasizes the importance of early detection due to more treatment and support opportunities available at earlier stages.
The study’s findings are specific to the Finnish population and lack verification of all medical diagnoses or assessment of their severity. Larger studies could explore these medical conditions’ roles as early indicators and their potential to enhance early detection.
Healthcare experts recommend consulting a provider if individuals experience persistent medical symptoms, including memory or cognition issues. Early diagnosis allows access to treatments, support, and planning opportunities for individuals and their families.